Eukaryotic protein recruitment into the Chlamydia inclusion: Implications for survival and growth

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Soupene, Eric ^a   Rothschild, James ^a   Kuypers, Frans A ^a   Dean, Deborah ^a,b,c,d  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYLGLYCEROPHOSPHOCHOLINE ACYLTRANSFERASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MEMBRANE PROTEIN; NUCLEAR PROTEIN; NUCLEAR PROTEIN ZNF23; PROTEIN ACBD6; PROTEIN ACSL3; PROTEIN LPCAT1; UNCLASSIFIED DRUG; ABC TRANSPORTER; ACBD6 PROTEIN, HUMAN; LPCAT1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZNF23 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INCLUSION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL SURVIVAL; BACTERIAL TRANSLOCATION; CELL MOTILITY; CELL ORGANELLE; CHLAMYDIA; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; CELL INCLUSION; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; HELA CELL; METABOLISM; MICROBIOLOGY; PROTEIN TRANSPORT;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; EUKARYOTA;

1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE; ATP-BINDING CASSETTE TRANSPORTERS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COENZYME A LIGASES; HELA CELLS; HUMANS; INCLUSION BODIES; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS;

EID: 84860713687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036843     Document Type: Article

References (66)

1. World-Health-Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates.
2. Hackstadt T, Fischer ER, Scidmore MA, Rockey DD, Heinzen RA, (1997) Origins and functions of the chlamydial inclusion. Trends Microbiol 5: 288-293.
3. Valdivia RH, (2008) Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Curr Opin Microbiol 11: 53-59.
4. Cocchiaro JL, Valdivia RH, (2009) New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 11: 1571-1578.
5. Saka HA, Valdivia RH, (2010) Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment. Curr Opin Microbiol 13: 4-10.
6. Albrecht M, Sharma CM, Reinhardt R, Vogel J, Rudel T, (2010) Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome. Nucleic Acids Res 38: 868-877.
7. Vandahl BB, Birkelund S, Christiansen G, (2004) Genome and proteome analysis of Chlamydia. Proteomics 4: 2831-2842.
8. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, et al. (1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282: 754-759.
9. Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, et al. (2006) A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 103: 14566-14571.
10. Peters J, Wilson DP, Myers G, Timms P, Bavoil PM, (2007) Type III secretion a la Chlamydia. Trends Microbiol 15: 241-251.
11. Rockey DD, Scidmore MA, Bannantine JP, Brown WJ, (2002) Proteins in the chlamydial inclusion membrane. Microbes Infect 4: 333-340.
12. van Ooij C, Kalman L, van I, Nishijima M, Hanada K, et al. (2000) Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell Microbiol 2: 627-637.
13. Capmany A, Damiani MT, (2010) Chlamydia trachomatis intercepts Golgi-derived sphingolipids through a Rab14-mediated transport required for bacterial development and replication. PLoS One 5: e14084.
14. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH, (2008) Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 105: 9379-9384.
15. Elwell CA, Jiang S, Kim JH, Lee A, Wittmann T, et al. (2011) Chlamydia trachomatis Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development. PLoS Pathog 7: e1002198.
16. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA, (1996) Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. Embo J 15: 964-977.
17. Hackstadt T, Scidmore MA, Rockey DD, (1995) Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 92: 4877-4881.
18. Kumar Y, Cocchiaro J, Valdivia RH, (2006) The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Curr Biol 16: 1646-1651.
19. Scidmore MA, Fischer ER, Hackstadt T, (1996) Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 134: 363-374.
20. Tse SM, Mason D, Botelho RJ, Chiu B, Reyland M, et al. (2005) Accumulation of diacylglycerol in the Chlamydia inclusion vacuole: possible role in the inhibition of host cell apoptosis. J Biol Chem 280: 25210-25215.
21. Robertson DK, Gu L, Rowe RK, Beatty WL, (2009) Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog 5: e1000664.
22. Wylie JL, Hatch GM, McClarty G, (1997) Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol 179: 7233-7242.
23. Lands WE, (1960) Metabolism of glycerolipids. 2. The enzymatic acylation of lysolecithin. J Biol Chem 235: 2233-2237.
24. Obata Y, Fukumoto Y, Nakayama Y, Kuga T, Dohmae N, et al. (2010) The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association. J Cell Sci 123: 2649-2662.
25. Soupene E, Kuypers FA, (2008) Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) 233: 507-521.
26. Soupene E, Serikov V, Kuypers FA, (2008) Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells. J Lipid Res 49: 1103-1112.
27. Huang C, Jia Y, Yang S, Chen B, Sun H, et al. (2007) Characterization of ZNF23, a KRAB-containing protein that is downregulated in human cancers and inhibits cell cycle progression. Exp Cell Res 313: 254-263.
28. Huang C, Yang S, Ge R, Sun H, Shen F, et al. (2008) ZNF23 induces apoptosis in human ovarian cancer cells. Cancer Lett 266: 135-143.
29. Nakanishi H, Shindou H, Hishikawa D, Harayama T, Ogasawara R, et al. (2006) Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production. J Biol Chem 281: 20140-20147.
30. Soupene E, Fyrst H, Kuypers FA, (2008) Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A 105: 88-93.
31. Byrne GI, Ojcius DM, (2004) Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2: 802-808.
32. Du K, Zheng Q, Zhou M, Zhu L, Ai B, et al. (2011) Chlamydial Antiapoptotic Activity Involves Activation of the Raf/MEK/ERK Survival Pathway. Curr Microbiol 63: 341-346.
33. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, et al. (2004) Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 200: 905-916.
34. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G, (2006) The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. J Biol Chem 281: 31495-31501.
35. Sharma M, Rudel T, (2009) Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS Immunol Med Microbiol 55: 154-161.
36. Verbeke P, Welter-Stahl L, Ying S, Hansen J, Hacker G, et al. (2006) Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog 2: e45.
37. Moessinger C, Kuerschner L, Spandl J, Shevchenko A, Thiele C, (2011) Human lysophosphatidylcholine acyltransferases 1 and 2 are located in lipid droplets where they catalyze the formation of phosphatidylcholine. J Biol Chem 286: 21330-21339.
38. Soupene E, Dinh NP, Siliakus M, Kuypers FA, (2010) Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem 11: 18.
39. Yao H, Ye J, (2008) Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J Biol Chem 283: 849-854.
40. Bannantine JP, Stamm WE, Suchland RJ, Rockey DD, (1998) Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect Immun 66: 6017-6021.
41. Hackstadt T, Scidmore-Carlson MA, Shaw EI, Fischer ER, (1999) The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol 1: 119-130.
42. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T, (1999) Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 33: 753-765.
43. Shindou H, Hishikawa D, Harayama T, Yuki K, Shimizu T, (2009) Recent progress on acyl CoA: lysophospholipid acyltransferase research. J Lipid Res 50 Supplpp. S46-51.
44. Shindou H, Shimizu T, (2009) Acyl-CoA:lysophospholipid acyltransferases. J Biol Chem 284: 1-5.
45. Hapala I, Marza E, Ferreira T, (2011) Is fat so bad? Modulation of endoplasmic reticulum stress by lipid droplet formation. Biol Cell 103: 271-285.
46. Fan J, Liu J, Culty M, Papadopoulos V, (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 49: 218-234.
47. Heuer D, Rejman Lipinski A, Machuy N, Karlas A, Wehrens A, et al. (2009) Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 457: 731-735.
48. Rejman Lipinski A, Heymann J, Meissner C, Karlas A, Brinkmann V, et al. (2009) Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84-dependent Golgi fragmentation. PLoS Pathog 5: e1000615.
49. Hasegawa A, Sogo LF, Tan M, Sutterlin C, (2009) Host complement regulatory protein CD59 is transported to the chlamydial inclusion by a Golgi apparatus-independent pathway. Infect Immun 77: 1285-1292.
50. Beatty WL, (2006) Trafficking from CD63-positive late endocytic multivesicular bodies is essential for intracellular development of Chlamydia trachomatis. J Cell Sci 119: 350-359.
51. Beatty WL, (2008) Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63. Infect Immun 76: 2872-2881.
52. Al-Younes HM, Rudel T, Meyer TF, (1999) Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells. Cell Microbiol 1: 237-247.
53. Wissel H, Schulz C, Rudiger M, Krull M, Stevens PA, et al. (2003) Chlamydia pneumoniae affect surfactant trafficking and secretion due to changes of type II cell cytoskeleton. Am J Respir Cell Mol Biol 29: 303-313.
54. Su H, McClarty G, Dong F, Hatch GM, Pan ZK, et al. (2004) Activation of Raf/MEK/ERK/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids. J Biol Chem 279: 9409-9416.
55. Fukuda EY, Lad SP, Mikolon DP, Iacobelli-Martinez M, Li E, (2005) Activation of lipid metabolism contributes to interleukin-8 production during Chlamydia trachomatis infection of cervical epithelial cells. Infect Immun 73: 4017-4024.
56. Fujimoto Y, Itabe H, Kinoshita T, Homma KJ, Onoduka J, et al. (2007) Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J Lipid Res 48: 1280-1292.
57. Ying S, Seiffert BM, Hacker G, Fischer SF, (2005) Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with Chlamydia trachomatis. Infect Immun 73: 1399-1403.
58. Schwarzenbacher R, Stenner-Liewen F, Liewen H, Robinson H, Yuan H, et al. (2004) Structure of the Chlamydia protein CADD reveals a redox enzyme that modulates host cell apoptosis. J Biol Chem 279: 29320-29324.
59. Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, et al. (2002) CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem 277: 9633-9636.
60. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926.
61. Zhong G, Fan P, Ji H, Dong F, Huang Y, (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942.
62. Scidmore MA, Hackstadt T, (2001) Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol 39: 1638-1650.
63. Somboonna N, Wan R, Ojcius DM, Pettengill MA, Joseph SJ, et al. (2011) Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages. MBio 2: e00045-00011.
64. Soupene E, Kuypers FA, (2006) Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol. Biol 7: 21.
65. Malhotra KT, Malhotra K, Lubin BH, Kuypers FA, (1999) Identification and molecular characterization of acyl-CoA synthetase in human erythrocytes and erythroid precursors. Biochem J 344 Pt 1: 135-143.
66. Shi YQ, Du LC, Wang QZ, Han CF, (2009) Ankrd7, a novel gene specifically expressed in Sertoli cells and its potential roles in Sertoli cell maturation. Mol Cells 27: 199-203.